Talk:Indiana Biosciences Research Institute

	United States portal This article is within the scope of WikiProject United States, a collaborative effort to improve the coverage of topics relating to the United States of America on Wikipedia. If you would like to participate, please visit the project page, where you can join the ongoing discussions. Template Usage Articles Requested! Become a Member Project Talk Alerts United StatesWikipedia:WikiProject United StatesTemplate:WikiProject United StatesUnited States
???	This article has not yet received a rating on the project's importance scale.
	Indiana portal This article is supported by WikiProject Indiana.

Ibricommsdirector

The following Wikipedia contributor may be personally or professionally connected to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.

Ibricommsdirector (talk · contribs)

I understand I may have a conflict of interest as I am the director of communications and engagement at the Indiana Bioscience Research Institute. I simply endeavor to update the entry to align with our current strategy and updated website that clearly identifies current board members, etc. Ibricommsdirector (talk) 15:51, 2 August 2022 (UTC)[reply]

{{request edit}} Please change opening short description to align with this organization's current strategy as reflected on its website, www.indianabiosciences.org.

A more appropriate short description might read, "The Indiana Biosciences Research Institute (IBRI) is an American nonprofit headquartered in Indianapolis, Indiana, within the 16 Tech Innovation District. The IBRI is a leading translational research institute that advances academic and industry science through collaboration to improve patient health outcomes. Its primary focus is on better understanding the pathogenesis of type 1 and type 2 diabetes. Its goal is to translate this knowledge into novel therapies, while also looking to expand into other diseases that share common systems and pathways." Ibricommsdirector (talk) 16:05, 2 August 2022 (UTC)[reply]

{{request edit}} Please add other social media channels to the external links.

IBRI on LinkedIn - https://www.linkedin.com/company/indiana-biosciences-research-institute

IBRI on Instagram - https://www.instagram.com/inbiosciences/

IBRI on Facebook - https://www.facebook.com/INBiosciences/ Ibricommsdirector (talk) 16:12, 2 August 2022 (UTC)[reply]

{{request edit}} Please remove the IBRI Scientific Advisory Board list as the organization no longer uses this board. Ibricommsdirector (talk) 16:16, 2 August 2022 (UTC)[reply]

{{request edit}} Please update the IBRI's Board of Directors to reflect the current list that includes:

Robert Bernhard, University of Notre Dame

Wayne Burris, Roche Diagnostics Corporation

Kenneth Custer, Eli Lilly and Company

Daniel Evans, Jr., Indiana University Health

Tatiana Foroud, Indiana University School of Medicine

Jay Hess, Indiana University

David Ingram, Indiana University Health

Cris Johnston, Indiana Office of Management and Budget

John Lechleiter, Eli Lilly and Company

Patricia Martin, BioCrossroads, Inc.

Theresa Mayer, Purdue University

Hany Moselhi, Roche Diagnostics North America

Alan Palkowitz, Indiana Biosciences Research Institute

Dan Peterson, Cook Group, Inc.

Aaron Schacht, BiomEdit, LLC

Wendy Srnic, Corteva Agriscience

Bill Stephan, Indiana University Ibricommsdirector (talk) 16:21, 2 August 2022 (UTC)[reply]